Company Overview
Snapshot
Founded in September 2017 by Yotam Zimmerman, Lightfective operates with 1–10 employees. The company has secured funding across one round. In January 2022, Lightfective obtained A Round funding.
Business overview
Lightfective is an innovator in medical and aesthetic technology, specializing in optimizing its patented Power LED technology for professional, constant-energy, light-based medical treatments. The company's core product, ReBorn, is a device designed for non-invasive fat reduction. ReBorn utilizes advanced LED technology to provide a safe and versatile light source, delivering uniform and homogenous heat specifically optimized for indications such as non-invasive professional fat reduction. Lightfective operates within the Health Tech & Life Sciences sector, focusing on medical devices, particularly aesthetic devices, and serves the healthcare market.
Strategic signal
In June 2022, Lightfective announced the continued international expansion of its ReBorn device. This expansion signals the company's growing market penetration and validates the global demand for its non-invasive fat reduction technology, indicating a positive trajectory for market adoption and revenue growth.
Log in to access full profile ›Company Intelligence Q&A
- What is Lightfective's primary product?
- Lightfective's primary product is ReBorn, a device that utilizes patented Power LED technology for non-invasive fat reduction treatments.
- When was Lightfective founded?
- Lightfective was founded in September 2017.
- Who is a co-founder of Lightfective?
- Yotam Zimmerman is a co-founder and CTO of Lightfective.
- What is Lightfective's main focus?
- Lightfective focuses on optimizing its patented Power LED technology for professional, constant-energy, light-based medical treatments, particularly for non-invasive fat reduction.
- What was a key development for Lightfective in June 2022?
- In June 2022, Lightfective announced the continued international expansion of its ReBorn device.